This March, we stand with the UK and global communities to raise awareness for brain tumours—a condition that impacts millions of lives.
Key Facts & Data
- Brain tumours are the leading cancer killer of children and young adults under 40 in the UK.
- Around 13,000 people are diagnosed with a primary brain tumour each year in the UK.
- The 5-year survival rate for malignant brain cancer in England is just 12.9%, far below the average for all cancers (56%).
- Globally, late-stage and complex brain tumours remain one of the most challenging conditions to treat.
Hope Through Advanced Healthcare
Early diagnosis, precise surgery, targeted therapies, and innovative treatments are transforming outcomes.
Today, China’s advanced critical care and neuroscience capabilities are opening new doors for international patients:
- High-precision neurosurgery, intraoperative imaging, and minimally invasive techniques
- Access to tumour treating fields (TTFields), targeted drugs, and novel immunotherapies
- Top-tier neurosurgical centers with extensive experience in complex and recurrent cases
- Streamlined international patient pathways: diagnosis → treatment → rehabilitation
Our International Medical Service
We connect global patients with China’s leading hospitals and top neurosurgical teams for world-class brain tumour treatment. We provide:
- International second opinion & specialist referral
- Full medical coordination & translation
- Visa, travel, and accommodation support
- Personalised critical care pathways
Every patient deserves timely access to the best possible care.
Mediversity Global is a comprehensive healthcare solutions provider that empowers healthcare professionals and advances the industry through education, connection, technology, and innovation.